Monitoring Testicular Tumours with a Blood Test
Author Information
Author(s): A.A. Epenetos, A.J. Munro, D.F. Tucker, W. Gregory, W. Duncan, R.H. MacDougall, M. Faux, P. Travers, W. F. Bodmer
Primary Institution: Imperial Cancer Research Fund, London
Hypothesis
Can serum placental alkaline phosphatase (PLAP) levels be used to monitor the disease status in patients with testicular germ cell tumours?
Conclusion
The study found that measuring PLAP levels is an important method for monitoring treatment response in patients with seminoma.
Supporting Evidence
- High levels of PLAP were found in all patients with active seminomas.
- Changing levels of PLAP correlated with the course of disease in patients with seminoma.
- Smokers had higher PLAP levels compared to non-smokers.
Takeaway
Doctors can check a blood test for a substance called PLAP to see if a patient with testicular cancer is getting better or worse.
Methodology
The study used a solid phase immunoassay to measure PLAP levels in serum samples from patients with germ cell tumours.
Potential Biases
The effect of smoking on PLAP levels could confound results.
Limitations
Elevated PLAP levels may not always indicate active disease, especially in smokers.
Participant Demographics
Patients had a mean age of 32 to 41 years, with various types of germ cell tumours.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website